Health

Results: 4417-4428 of 8220

RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to +4.6 cm/year in Children 5 Years of Age and Older in the Low Dose Cohort

PR Newswire associated0

INTRODUCING JUICE PLUS+ LUMINATE: ONE OF THE FIRST, RAPID ACTING, PLANT-BASED PRODUCTS DESIGNED TO SUPPORT MENTAL CLARITY, FOCUS, AND ENERGY

PR Newswire associated0

Chemonics Acquires Berlin-Based Luvent Consulting, Strengthening Its Global Reach

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

David Meek is proposed as new Chair of the Board of Directors of Sobi

Shelley Gandhi joins ELIQUENT Life Sciences - bolsters expanded Pharmacovigilance & Risk Management Solutions (Photo: Business Wire)

Shelley Gandhi Joins Firm – Headlines ELIQUENT’s Expanded Pharmacovigilance Service Offerings

Dechert Advises Poxel on US$50 Million Non-Dilutive Financing Agreement with OrbiMed

Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei

PR Newswire associated0

European leader in contamination control, has presented at the Annual Strategic Meeting the strategies which will guide its global expansion in the next five years

PR Newswire associated0

CATALYX AND INEL FORGE STRATEGIC PARTNERSHIP TO ADVANCE PACKAGING AUTOMATION IN PHARMACEUTICAL MANUFACTURING

PR Newswire associated0

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network